物理化学学报
物理化學學報
물이화학학보
ACTA PHYSICO-CHIMICA SINICA
2010年
4期
1093-1098
,共6页
魏平%李春梅%周璐%刘莹%来鲁华
魏平%李春梅%週璐%劉瑩%來魯華
위평%리춘매%주로%류형%래로화
别构效应%SAGS%3CL蛋白酶%分析型超速离心%底物增强的酶二聚化
彆構效應%SAGS%3CL蛋白酶%分析型超速離心%底物增彊的酶二聚化
별구효응%SAGS%3CL단백매%분석형초속리심%저물증강적매이취화
Allosteric effect%SARS%3CL proteinase%Analytical ultracentrifugation%Substrate enhanced enzyme dimerization
研究了严重急性呼吸系统综合症(SARS)冠状病毒3C-Like蛋白酶(3CLpro)在存在底物或抑制剂时的二聚体形成情况.通过测定酶活性随酶浓度的变化,拟合出在底物存在下酶二聚体的解离常数约为0.94 μmol·L~(-1),小于纯蛋白酶的二聚体解离常数(14.0μmol·L~(-1)),表明底物对二聚体的形成具有增强作用.选用与底物具有类似结合方式的靛红类抑制剂N-萘甲基靛红-5-甲酰胺(5f),利用超速离心沉降速率方法定量测定了SARS 3CL蛋白酶单体和二聚体在不同浓度5f时的含量,发现5f同样具有诱导二聚体形成的能力.在3 μmol·L~(-1)蛋白酶浓度下测定得到诱导二聚的EC_(50)值(半数有效浓度)约为1μmol·L~(-1),说明二聚体中只有一个单体与抑制剂结合.研究结果表明,随着底物浓度的升高,SARS 3CL蛋白酶会形成更多的二聚体,而二聚体含量的提高又反过来提高酶的活性,这种双向别构调控机制有可能是病毒用来调控多聚蛋白水解速率和组装时机的一种方法.
研究瞭嚴重急性呼吸繫統綜閤癥(SARS)冠狀病毒3C-Like蛋白酶(3CLpro)在存在底物或抑製劑時的二聚體形成情況.通過測定酶活性隨酶濃度的變化,擬閤齣在底物存在下酶二聚體的解離常數約為0.94 μmol·L~(-1),小于純蛋白酶的二聚體解離常數(14.0μmol·L~(-1)),錶明底物對二聚體的形成具有增彊作用.選用與底物具有類似結閤方式的靛紅類抑製劑N-萘甲基靛紅-5-甲酰胺(5f),利用超速離心沉降速率方法定量測定瞭SARS 3CL蛋白酶單體和二聚體在不同濃度5f時的含量,髮現5f同樣具有誘導二聚體形成的能力.在3 μmol·L~(-1)蛋白酶濃度下測定得到誘導二聚的EC_(50)值(半數有效濃度)約為1μmol·L~(-1),說明二聚體中隻有一箇單體與抑製劑結閤.研究結果錶明,隨著底物濃度的升高,SARS 3CL蛋白酶會形成更多的二聚體,而二聚體含量的提高又反過來提高酶的活性,這種雙嚮彆構調控機製有可能是病毒用來調控多聚蛋白水解速率和組裝時機的一種方法.
연구료엄중급성호흡계통종합증(SARS)관상병독3C-Like단백매(3CLpro)재존재저물혹억제제시적이취체형성정황.통과측정매활성수매농도적변화,의합출재저물존재하매이취체적해리상수약위0.94 μmol·L~(-1),소우순단백매적이취체해리상수(14.0μmol·L~(-1)),표명저물대이취체적형성구유증강작용.선용여저물구유유사결합방식적전홍류억제제N-내갑기전홍-5-갑선알(5f),이용초속리심침강속솔방법정량측정료SARS 3CL단백매단체화이취체재불동농도5f시적함량,발현5f동양구유유도이취체형성적능력.재3 μmol·L~(-1)단백매농도하측정득도유도이취적EC_(50)치(반수유효농도)약위1μmol·L~(-1),설명이취체중지유일개단체여억제제결합.연구결과표명,수착저물농도적승고,SARS 3CL단백매회형성경다적이취체,이이취체함량적제고우반과래제고매적활성,저충쌍향별구조공궤제유가능시병독용래조공다취단백수해속솔화조장시궤적일충방법.
The 3C-like proteinase(3CLpro)of severe acute respiratory syndrome(SARS)coronavirus has been proposed to be a key target for anti-SARS drug discovery.It has been proposed and verified that the dimer was the active form of 3CLpro and only one protomer is active.In our previous work,We measmed the dissocialion constant(K_d) of the purified SARS 3CLpro using analytical ultracentrifugation at around 14.0μmol·L~(-1).Using this K_d value,most of the SARS 3CLpro in the in vitro activity assay(1-3 μmol·L~(-1))might be in the monomer form and inactive.To explain this dilemma,we measured the enzyme activity change together with the enzyme concentration.By fitting the concentration dependent activity profile,the apparent dissociation constant was found to be 0.94 μmol·L~(-1),indicating a clear tendency toward substrate enhanced dimerization.This also explains why SARS 3CLpro was still active in the in vitro activity assay under a relatively low enzyme concentration.To further verify the substrate induced dimerization phenomenon,we selected a previously reported SARS 3CLpro isatin inhibitor,1-(2-naphthlmethyl)isatin-5-carboxamide(5f),which has similar binding.interactions with the subarate and we studied its influence on SARS 3CLpro dimer formation using analytical ultracentrifugation.5f showed a strong ability to induce SARS 3CLpro dimer formtion.By measuring the dimer and monomer distribution under different 5f concentrations,the EC_(50)of dimer induction was found to be about1.0 μmol·L~(-1)under an enzyme concentration of 3.0 μmol·L~(-1).This implies that only one protomer in the SARS 3CLpro dimer binds to the inhibitor or the substrate.As the apparent association constant and thus the enzyme activity of SARS 3CLpro increases with the concentration of the substrate,this may be a smart way to allosterically regulate the hydrolysis of the SARS viral polyproteins and the correct assembly of virons.